Toxicity risk from glucocorticoids in sarcoidosis patients

Glucocorticoids (GC) are considered first-line therapy for treating sarcoidosis, but there are few data about the adverse consequences of GC. Although there are several steroid-sparing medications available for treatment, a large proportion of patients are treated with prolonged courses of GC. The toxicities of GC in sarcoidosis populations have not been carefully evaluated.

Source: Respiratory Medicine - September 8, 2017 Category: Respiratory Medicine Authors: Nauman Khan, Christopher V. Donatelli, Adriano R. Tonelli, Jonathan Wiesen, Manuel L. Ribeiro Neto, Debasis Sahoo, Daniel A. Culver Source Type: research